Filed: 5/15/2026ACC: 0001856083-26-000003
📋 What this filing means
DEEP TRACK CAPITAL, LP filed this quarterly 13F‑HR report disclosing 63 equity positions with a total reported market value of $6.12B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
63
Positions
$6.12B
Total AUM (reported)
263.76M
Total Shares
Allocation by class
COM$3.42B55.9%
STATE STREET SPD$1.28B20.9%
SPONSORED ADS$497.26M8.1%
COM NEW$223.19M3.6%
COM SHS$192.47M3.1%
CL A$169.13M2.8%
SHS$126.95M2.1%
Portfolio Concentration
Top 3$1.87B30.6%
4–10$1.41B23.0%
11–25$1.63B26.7%
Rest$1.21B19.7%
Top 3 weight
30.6%
Top 10 weight
53.6%
Voting Authority Distribution
Total shares with voting rights: 263.76M
Sole
Full voting authority
263.76M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole63
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings63
Rows:
SPDR SERIES TRUST
SOLEShares10M
TypeSH
Market value$1.28B
20.86%
Sole
10M
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares3.34M
TypeSH
Market value$308.35M
5.04%
Sole
3.34M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares11.53M
TypeSH
Market value$286.33M
4.68%
Sole
11.53M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares3.60M
TypeSH
Market value$252.54M
4.12%
Sole
3.60M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares4.30M
TypeSH
Market value$249.87M
4.08%
Sole
4.30M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares4.28M
TypeSH
Market value$206.29M
3.37%
Sole
4.28M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC.
SOLEShares1.10M
TypeSH
Market value$185.92M
3.04%
Sole
1.10M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares4.53M
TypeSH
Market value$182.34M
2.98%
Sole
4.53M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares19.69M
TypeSH
Market value$166.74M
2.72%
Sole
19.69M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares4.11M
TypeSH
Market value$165.19M
2.70%
Sole
4.11M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares6.77M
TypeSH
Market value$149.20M
2.44%
Sole
6.77M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares1.95M
TypeSH
Market value$146.43M
2.39%
Sole
1.95M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares1.38M
TypeSH
Market value$141.00M
2.30%
Sole
1.38M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares3.59M
TypeSH
Market value$126.95M
2.07%
Sole
3.59M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares3.16M
TypeSH
Market value$125.44M
2.05%
Sole
3.16M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares6.41M
TypeSH
Market value$119.46M
1.95%
Sole
6.41M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares3.48M
TypeSH
Market value$103.81M
1.70%
Sole
3.48M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares2.03M
TypeSH
Market value$99.78M
1.63%
Sole
2.03M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares6.35M
TypeSH
Market value$98.35M
1.61%
Sole
6.35M
Shared
0.00
None
0.00
GENMAB A/S
SOLEShares3.66M
TypeSH
Market value$98.28M
1.61%
Sole
3.66M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares1.37M
TypeSH
Market value$90.58M
1.48%
Sole
1.37M
Shared
0.00
None
0.00
GRAIL INC
SOLEShares1.72M
TypeSH
Market value$89.03M
1.45%
Sole
1.72M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares3.35M
TypeSH
Market value$82.68M
1.35%
Sole
3.35M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares2.76M
TypeSH
Market value$82.31M
1.34%
Sole
2.76M
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares4.06M
TypeSH
Market value$80.80M
1.32%
Sole
4.06M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SERIES TRUSTSOLE | STATE STREET SPD | 10M | SH | $1.28B 20.86% | 10M | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 3.34M | SH | $308.35M 5.04% | 3.34M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 11.53M | SH | $286.33M 4.68% | 11.53M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 3.60M | SH | $252.54M 4.12% | 3.60M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 4.30M | SH | $249.87M 4.08% | 4.30M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 4.28M | SH | $206.29M 3.37% | 4.28M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INC.SOLE | COM | 1.10M | SH | $185.92M 3.04% | 1.10M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 4.53M | SH | $182.34M 2.98% | 4.53M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 19.69M | SH | $166.74M 2.72% | 19.69M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 4.11M | SH | $165.19M 2.70% | 4.11M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 6.77M | SH | $149.20M 2.44% | 6.77M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 1.95M | SH | $146.43M 2.39% | 1.95M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 1.38M | SH | $141.00M 2.30% | 1.38M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 3.59M | SH | $126.95M 2.07% | 3.59M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 3.16M | SH | $125.44M 2.05% | 3.16M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 6.41M | SH | $119.46M 1.95% | 6.41M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 3.48M | SH | $103.81M 1.70% | 3.48M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 2.03M | SH | $99.78M 1.63% | 2.03M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 6.35M | SH | $98.35M 1.61% | 6.35M | 0.00 | 0.00 |
GENMAB A/SSOLE | SPONSORED ADS | 3.66M | SH | $98.28M 1.61% | 3.66M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 1.37M | SH | $90.58M 1.48% | 1.37M | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 1.72M | SH | $89.03M 1.45% | 1.72M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 3.35M | SH | $82.68M 1.35% | 3.35M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 2.76M | SH | $82.31M 1.34% | 2.76M | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 4.06M | SH | $80.80M 1.32% | 4.06M | 0.00 | 0.00 |
Page 1 of 3